New York, New York--(Newsfile Corp. - November 18, 2025) - If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ: ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=177902&wire=5&utm_campaign=20or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.Cannot ...